Tweet
Hi everyone, does someone know why the Busco's website doesn't work?
Thanks you
busco.ezlab.org
Thanks you
busco.ezlab.org
-
-
It's down.
You can find links to the code and datasets there. -
Thanks uoi Kukowski i found it thanks to you.Originally posted by Bukowski View PostIt's down.
You can find links to the code and datasets there.
Now i'm having a probleme, I don't know if you know a solution?
I used this code:
python run_BUSCO.py -i ACG-0042-scaffold.fa -o busco_output -l hymenoptera_odb9 -m geno
And I got this message error:
ERROR No section [busco] found in /home/ivan/Bureau/STAGE/BUSCO/Busco/scripts/../config/config.ini. Please make sure both the file and this section exist, see userguide.
Do you know what is the probleme?Comment
-
So, I had this problem- it could be due to two things:
(1) By default BUSCO has a file called. That file needs to modified and renamed asCode:/path-to-busco-installation/busco/config/config.ini.default
.Code:/path-to-busco-installation/busco/config/config.ini
(2) You may have solved problem (1), but you removed the lines between sections. For example,
BUSCO will give that error if you have:
But no error with the following:Code:[tblastn] # path to tblastn path = /usr/bin/ [makeblastdb] # path to makeblastdb path = /usr/bin/
Code:[tblastn] # path to tblastn path = /usr/bin/ [makeblastdb] # path to makeblastdb path = /usr/bin/
Comment
-
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...07-08-2026, 05:17 AM
Comment